Molecular surveillance of chloroquine-resistant Plasmodium falciparum in sub-Saharan African countries after withdrawal of chloroquine for treatment of uncomplicated malaria: A systematic review

被引:11
|
作者
Njiro, Belinda J. [1 ]
Mutagonda, Ritah F. [1 ]
Chamani, Amisa T. [1 ]
Mwakyandile, Tosi [1 ]
Sabas, Deodatus [1 ]
Bwire, George M. [1 ]
机构
[1] Muhimbili Univ Hlth & Allied Sci, POB 65001, Dar Es Salaam, Tanzania
关键词
Chloroquine; Sub-Saharan Countries; Plasmodium falciparum; Pfcrt; Pfmdr1; ANTIMALARIAL-DRUG RESISTANCE; TRANSPORTER GENE; MARKERS; PFCRT; SUSCEPTIBILITY; LUMEFANTRINE; PREVALENCE; MUTATIONS; GENOTYPES; DISTRICT;
D O I
10.1016/j.jiph.2022.03.015
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: A wide spread of chloroquine resistance prompted its discontinued use for treatment of uncomplicated malaria in several African countries. However, disappearances of chloroquine-resistant parasites have been reported in areas with restricted use of chloroquine. This review reports the current prevalence of chloroquine-resistant Plasmodium falciparum using Pfcrt K76T and Pfmdr1 N86Y genotypes. Methods: A PROSPERO registered systematic review searched evidence from PubMed/MEDLINE, Science Direct and Google Scholar. The search included studies on chloroquine-resistant/ susceptible P. falciparum in humans between January 1st, 2000 and May 15th, 2020. The search was conducted on 15th of May, 2020. Results: Out of 519 searched records, 15 studies qualified for final analysis with 8040 samples genotyped for Pfcrt K76T. Of 8040, 43.6% (837/1572; 95%CI: -0.9 to 88.1%) carried resistant genotypes versus 23.0% (1477/ 6468; 95%CI: 15.7-30.2%) while for 4698 samples analyzed for Pfmdr1 N86Y, 52.4% (592/1090; 95%CI: 42.3-62.5%) had resistant genotypes versus 25.9% (1314/3608; 95%CI: 5.8-46.0%), before and after chloroquine withdrawal, respectively. The median time since chloroquine withdrawal to data collection was 7.0 (interquartile range: 4.5-13.5) years. Low prevalence of resistant genotypes (Pfcrt K76T) was reported in Zambia (0%) in 2013, Malawi (0.1%) in 2009, Tanzania (0.2%) in 2018 and Madagascar (0.3%) in 2007 with significant variations in the included studies. Conclusions: Chloroquine-resistant P. falciparum continues to disappear in countries with withdrawal of chloroquine. Areas with significant susceptible parasites, reintroduction of chloroquine can be considered, preferably in combination with other safe and affordable antimalarials. (c) 2022 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. CC_BY_NC_ND_4.0
引用
收藏
页码:550 / 557
页数:8
相关论文
共 26 条
  • [21] Therapeutic efficacy of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Sub-Saharan Africa: A systematic review and meta-analysis
    Marwa, Karol
    Kapesa, Anthony
    Baraka, Vito
    Konje, Evelyne
    Kidenya, Benson
    Mukonzo, Jackson
    Kamugisha, Erasmus
    Swedberg, Gote
    PLOS ONE, 2022, 17 (03):
  • [22] Prevalence of the molecular marker of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in Benin seven years after the change of malaria treatment policy
    Aurore Ogouyèmi-Hounto
    Nicaise Tuikue Ndam
    Dorothée Kinde Gazard
    Sitou d’Almeida
    Lucette Koussihoude
    Elvire Ollo
    Carmine Azagnandji
    Mourchidath Bello
    Jean-Phillipe Chippaux
    Achille Massougbodji
    Malaria Journal, 12
  • [23] Molecular surveillance for anti-malarial drug resistance and genetic diversity of Plasmodium falciparum after chloroquine and sulfadoxine-pyrimethamine withdrawal in Quibdo, Colombia, 2018
    Angela Patricia Guerra
    Mario Javier Olivera
    Liliana Jazmín Cortés
    Stella M. Chenet
    Alexandre Macedo de Oliveira
    Naomi W. Lucchi
    Malaria Journal, 21
  • [24] Making data map-worthy—enhancing routine malaria data to support surveillance and mapping of Plasmodium falciparum anti-malarial resistance in a pre-elimination sub-Saharan African setting: a molecular and spatiotemporal epidemiology study
    Frank M. Kagoro
    Elizabeth Allen
    Aaron Mabuza
    Lesley Workman
    Ray Magagula
    Gerdalize Kok
    Craig Davies
    Gillian Malatje
    Philippe J. Guérin
    Mehul Dhorda
    Richard J. Maude
    Jaishree Raman
    Karen I. Barnes
    Malaria Journal, 21
  • [25] The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis
    Robert J. Commons
    Julie A. Simpson
    Kamala Thriemer
    Cindy S. Chu
    Nicholas M. Douglas
    Tesfay Abreha
    Sisay G. Alemu
    Arletta Añez
    Nicholas M. Anstey
    Abraham Aseffa
    Ashenafi Assefa
    Ghulam R. Awab
    J. Kevin Baird
    Bridget E. Barber
    Isabelle Borghini-Fuhrer
    Umberto D’Alessandro
    Prabin Dahal
    André Daher
    Peter J. de Vries
    Annette Erhart
    Margarete S. M. Gomes
    Matthew J. Grigg
    Jimee Hwang
    Piet A. Kager
    Tsige Ketema
    Wasif A. Khan
    Marcus V. G. Lacerda
    Toby Leslie
    Benedikt Ley
    Kartini Lidia
    Wuelton M. Monteiro
    Dhelio B. Pereira
    Giao T. Phan
    Aung P. Phyo
    Mark Rowland
    Kavitha Saravu
    Carol H. Sibley
    André M. Siqueira
    Kasia Stepniewska
    Walter R. J. Taylor
    Guy Thwaites
    Binh Q. Tran
    Tran T. Hien
    José Luiz F. Vieira
    Sonam Wangchuk
    James Watson
    Timothy William
    Charles J. Woodrow
    Francois Nosten
    Philippe J. Guerin
    BMC Medicine, 17
  • [26] The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis
    Commons, Robert J.
    Simpson, Julie A.
    Thriemer, Kamala
    Chu, Cindy S.
    Douglas, Nicholas M.
    Abreha, Tesfay
    Alemu, Sisay G.
    Anez, Arletta
    Anstey, Nicholas M.
    Aseffa, Abraham
    Assefa, Ashenafi
    Awab, Ghulam R.
    Baird, J. Kevin
    Barber, Bridget E.
    Borghini-Fuhrer, Isabelle
    D'Alessandro, Umberto
    Dahal, Prabin
    Daher, Andre
    de Vries, Peter J.
    Erhart, Annette
    Gomes, Margarete S. M.
    Grigg, Matthew J.
    Hwang, Jimee
    Kager, Piet A.
    Ketema, Tsige
    Khan, Wasif A.
    Lacerda, Marcus V. G.
    Leslie, Toby
    Ley, Benedikt
    Lidia, Kartini
    Monteiro, Wuelton M.
    Pereira, Dhelio B.
    Phan, Giao T.
    Phyo, Aung P.
    Rowland, Mark
    Saravu, Kavitha
    Sibley, Carol H.
    Siqueira, Andre M.
    Stepniewska, Kasia
    Taylor, Walter R. J.
    Thwaites, Guy
    Tran, Binh Q.
    Hien, Tran T.
    Vieira, Jose Luiz F.
    Wangchuk, Sonam
    Watson, James
    William, Timothy
    Woodrow, Charles J.
    Nosten, Francois
    Guerin, Philippe J.
    BMC MEDICINE, 2019, 17 (1)